Category: Disease Discoveries
-
Tumor Mutations Predict Response to Immunotherapy
A recent Northwestern Medicine study found that patients with glioblastoma responded better or worse to immunotherapy depending on the presence of certain mutations in their tumors.
-
Alzheimer’s Treatment Holds Promise for Primary Progressive Aphasia Patients
Northwestern Medicine scientists have discovered that an existing therapy used to treat Alzheimer’s disease might also work on patients with Primary Progressive Aphasia, a type of dementia that destroys language and currently has no treatment.
-
Nanoparticle Peptides Could Fight Neurodegenerative Disease
According to a recent study, a novel nanoparticle-based drug repaired neurons and improved microvasculature in a mouse model of spinocerebellar ataxia 1, a degenerative disease that affects the cerebellum.
-
New Group of Neurons Implicated in Parkinson’s Disease
Abnormal activation of a small population of neurons may contribute to motor learning and motor function deficits in patients with Parkinson’s disease, according to a recent study.
-
Therapeutic Toxins
Northwestern investigators are exploring the potential of bacterial toxins to be turned into therapeutic agents to effectively ward off disease.
-
Solving Resistance to Emerging Cancer Immunotherapy
According to a recent study, Northwestern scientists have pinpointed how an ectoenzyme called CD73 undermines the effectiveness of an emerging cancer therapy.
-
New Role for Dopamine in Deadly Brain Cancer
A Northwestern Medicine study has demonstrated the role of dopamine in the progression of glioblastoma and suggests that targeting the neurotransmitter may slow cancer growth.
-
Long-Term Income Volatility Linked to Cardiovascular Disease
According to a recent study, significant changes or drops in income can increase the risk of cardiovascular disease, suggesting people in those situations should be a priority for interventions such as screenings.
-
New Fragile X Genes Discovered
A genome-wide analysis revealed nine new genes associated with fragile X syndrome, findings that shed light on the complex hereditary mechanisms behind the genetic disease.
-
Study Suggests New Strategy to Treat Advanced Prostate Cancer
A Northwestern Medicine study provides new insights into a signaling pathway in metastatic prostate cancer and suggests that a novel drug combination may improve treatment response and slow cancer growth.
